- Vaccines for Diarrheal Diseases
-
Park SE
- KMID: 2278915
- Korean J Pediatr Infect Dis.
- 2009 Dec;16(2):115-122.
Diarrhea is one of the most common causes of morbidity and mortality in children worldwide. Rotavirus is the most common cause of infectious diarrhea both in developed and developing countries.... -
- CITED
-
- Close
- SHARE
-
- Close
- Infectious Disease Prevention for Travelers
-
Choi YH
- KMID: 2064943
- J Korean Med Assoc.
- 2005 Aug;48(8):777-783.
- doi: 10.5124/jkma.2005.48.8.777
Vaccination against yellow fever is recommended for travelers to areas where yellow fever has been reported, and they should be vaccinated 10 days before the travel at an approved center... -
- CITED
-
- Close
- SHARE
-
- Close
- Evaluation of Immune Response for Vi-CRM(197) Conjugated Vaccine against Salmonella enterica serovar Typhi in Mice
-
Kim K, Shim J, Park S, Park B, Cho Y, Hur B, Kang SA, Choi SK, Baik Y, Hahn TW
- KMID: 2135357
- J Bacteriol Virol.
- 2014 Mar;44(1):52-58.
- doi: 10.4167/jbv.2014.44.1.52
Typhoid fever, a serious systemic infection caused by Salmonella enterica serovar Typhi, breaks out in developing countries. However, existing vaccines only induce relatively low protective effects with humoral responses and... -
- CITED
-
- Close
- SHARE
-
- Close
- Travel Pattern and Prescription Analysis at a Single Travel Clinic Specialized for Yellow Fever Vaccination in South Korea
-
Chin BS, Kim JY, Gianella S, Lee M
- KMID: 2170513
- Infect Chemother.
- 2016 Mar;48(1):20-30.
- doi: 10.3947/ic.2016.48.1.20
BACKGROUND: Travel-related risks for infectious diseases vary depending on travel patterns such as purpose, destination, and duration. In this study, we describe the patterns of travel and prescription of vaccines... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Purified Vi Polysaccharide Typhoid Vaccine
-
Park JH, Hong JJ, Choi ES, Lee JW, Park JH
- KMID: 1095363
- J Vet Sci.
- 2002 Jun;3(2):67-70.
This experiment was conducted to assess the efficacy of typhoid vaccine newly produced by purifying Vi antigen of Salmonella typhi. With Karber method, LD50 of challenging organism (S. typhi ty2)... -
- CITED
-
- Close
- SHARE
-
- Close
- Immunogenicity of Vi capsular polysaccharide vaccine evaluated for three years in Korea
-
Kim YR, Yoo JH, Hur JK, Kang JH, Shin WS, Kang MW
- KMID: 644895
- J Korean Med Sci.
- 1995 Oct;10(5):314-317.
- doi: 10.3346/jkms.1995.10.5.314
The immunogenicity of a single dose of Salmonella typhi(S.typhi) Vi capsular polysaccharide(CPS) vaccine was evaluated before, and at 1, 3, 12, and 36 months after vaccination. Eighty-five adults(20-28 years of... -
- CITED
-
- Close
- SHARE
-
- Close
